Viewing Study NCT00588835


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2026-03-26 @ 7:53 PM
Study NCT ID: NCT00588835
Status: TERMINATED
Last Update Posted: 2020-11-30
First Post: 2007-12-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients
Sponsor: Radboud University Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: UMCN-AKF 07.02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Dr. D. Burger, hospital pharmacist
Old Organization: Radboud University Nijmegen Medical Centre

Collaborators

Collaborators

Name Class View
None INDUSTRY View